Tigress Financial Reiterates Buy on Starbucks, Maintains $136 Price Target
Tigress Financial analyst Ivan Feinseth reiterates Starbucks (NASDAQ:SBUX) with a Buy and maintains $136 price target.
Tesla China’s ‘Success Story Back On Track,’ Says Analyst: 76% EV Buyers Prefer Model 3, Y Over BYD, Nio
The fears concerning demand slowdown for Tesla Inc.
Morgan Stanley Thinks United Airlines’ Strong Guidance Is Achievable
Morgan Stanley analyst Ravi Shanker reiterated an Overweight rating on the shares of United Airlines Holdings Inc (NASDAQ:UAL) with a price target…
This Analyst Still Has Confidence In Atai Life Sciences’ Pipeline Despite Recent Setbacks
HC Wainwright lowered the price target for Atai Life Sciences N.V. (NASDAQ:ATAI) from $50 to $20 to reflect recent adverse outcomes in programs…
Here’s Why This Analyst Seems Highly Convinced With Evolus’ Outlook
Evolus Inc (NASDAQ: EOLS) issued fourth-quarter 2022 and full-year 2022 revenues of $43.6 million, up 26% Y/Y and approximately $148.6 million, up 49%, respectively.
J.B. Hunt Transport Services’ Room For Intermodal Growth Prompts 4% Price Target Hike By This Analyst
Raymond James analyst Patrick Tyler Brown reiterated an Outperform rating on the shares of J.B. Hunt Transport Services Inc (NASDAQ: JBHT) and raised the price target from $195 to $203.
Micron To Register Negative Margins In 3Q Due To Supply-Demand Gap, Analyst Says
Needham analyst Rajvindra Gill reiterated a Buy rating on Micron Technology, Inc (NASDAQ: MU)
Analyst Views Novo Nordisk’s Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly’s Tirzepatide
Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's (NYSE: NVO) SELECT CV outcomes study, which is guided to complete in ~mid-2023.
Microsoft’s Downsizing Does Not Surprise Analysts; Remain Bullish On Cloud Driven Growth Opportunities
Microsoft Corp (NASDAQ:MSFT) confirmed it is reducing its headcount by roughly 10K employees, equating to 4% – 5% of…